Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Стратегии консервативного лечения эндометриоидных кист яичников
Стратегии консервативного лечения эндометриоидных кист яичников
Макаренко Т.А., Галкина Д.Е., Борисова Е.А. Стратегии консервативного лечения эндометриоидных кист яичников. Гинекология. 2023;25(1):4–10. DOI: 10.26442/20795696.2023.1.201803
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Эндометриоз остается одним из самых актуальных заболеваний в современной гинекологии и представляет собой мультифакторное состояние, при котором происходит разрастание за пределами полости матки ткани, по морфологическим и функциональным свойствам подобной эндометрию. Известно, что одной из наиболее часто диагностируемых форм эндометриоза являются эндометриоидные кисты яичников. Важная особенность клинического течения эндометриоза яичников – его негативное влияние на репродуктивную функцию и рецидивирующий характер заболевания, что создает предпосылки к повторным хирургическим вмешательствам и еще большему повреждению ткани яичников. В связи с этим наиболее актуальной является разработка стратегии долговременного медикаментозного лечения пациенток с эндометриоидными кистами в анамнезе, направленной на предотвращение рецидивов. При этом в качестве терапии 1-й линии для таких пациенток, согласно отечественным и зарубежным клиническим рекомендациям, предложена гормонотерапия прогестагенами. Одним из наиболее изученных в клинической практике препаратов с доказанным в ходе многочисленных исследований благоприятным профилем эффективности и безопасности является диеногест. В статье представлен зарубежный и отечественный опыт проведения консервативной терапии среди больных с эндометриоидными кистами в анамнезе при помощи препарата диеногест в аспекте его противорецидивного влияния.
Ключевые слова: эндометриома, эндометриоидная киста, диеногест, рецидив эндометриом, лапароскопическая энуклеация, цистэктомия
Keywords: endometrioma, endometrioid cyst, dienogest, endometrioma recurrence, laparoscopic enucleation, cystectomy
Ключевые слова: эндометриома, эндометриоидная киста, диеногест, рецидив эндометриом, лапароскопическая энуклеация, цистэктомия
________________________________________________
Keywords: endometrioma, endometrioid cyst, dienogest, endometrioma recurrence, laparoscopic enucleation, cystectomy
Полный текст
Список литературы
1. Endometriosis. Guideline of European Society of Human Reproduction and Embryology. 2022, 192 р.
2. Surrey ES. Endometriosis and assisted reproductive technologies: maximizing outcomes. Semin Reprod Med. 2013;31:154-63.
3. Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1-15. DOI:10.1016/j.bpobgyn. 2018.06.001
4. Эндометриоз. Клинические рекомендации. 2020 [Endometrioz. Klinicheskie rekomendatsii. 2020 (in Russian)].
5. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.
6. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Management of endometriomas. Semin Reprod Med. 2017;35(1):25-30. DOI:10.1055/s-0036-1597126
7. Stern JE, Luke B, Tobias M, et al. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril. 2015;103:1438-45.
8. Cohen J, Ziyyat A, Naoura I, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2015;32:263-70.
9. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
10. Gater A, Taylor F, Seitz C, et al. Development and content validation of two new patientreported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS). J Patient Rep Outcomes. 2020;4:13.
11. Ruan HC, Zhu XM, Luo Q, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21:2521-9.
12. Печеникова В.А., Костючек Д.Ф., Дурасова Е.Н. Клинико-морфологические и морфофункциональные особенности эндометриоза яичников. Журнал акушерства и женских болезней. 2010;59(5):110-7 [Pechenikova VA, Kostiuchek DF, Durasova EN. Kliniko-morfologicheskie i morfofunktsional'nye osobennosti endometrioza iaichnikov. Zhurnal akusherstva i zhenskikh boleznei. 2010;59(5):110-7 (in Russian)].
13. Sanchez AM, Viganò P, Somigliana E, et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014;20(2):217-30.
14. Garcia-Velasco A, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496-501.
15. Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1043-57. DOI:10.1007/s00404-017-4640-1
16. Давыдов А.И., Стрижаков М.А., Пашков В.М. Аспирационное лечение эндометриоидных кист яичников: за и против. Вопросы гинекологии, акушерства и перинатологии. 2004;3(3):88-90 [Davydov AI, Strizhakov MA, Pashkov VM. Aspiracionnoe lechenie endometrioidnyh kist yaichnikov: za i protiv. Voprosy ginekologii, akusherstva i perinatologii. 2004;3(3):88-90 (in Russian)].
17. Сидорова И.С., Унанян А.Л., Коган Е.А., и др. Клинико-патогенетические особенности эндометриоидных поражений яичников: возможности прогнозирования и профилактики рецидивов. Вопросы гинекологии, акушерства и перинатологии. 2007;6(1):18-23 [Sidorova IS, Unanyan AL, Kogan EA. Clinicopathogenetic specificity of endometrioid ovarian affection: possibilities of prognosing and preventing relapses. Gynecology, Obstetrics and Perinatology. 2007;6(1):18-23 (in Russian)].
18. Brosens I, Puttemans P, Gordts S, et al. Early stage management of ovarian endometrioma to prevent infertility. Facts Views Vis Obgyn. 2013;5(4):309-14.
19. Piriyev E, Schiermeier S, Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur J Obstet Gynecol Reprod Biol. 2021;263:20-4.
20. Vigano P, Somigliana E, Gentilin D, et al. Back to the original question in endometriosis: implantation or metaplasia? J Endometr. 2009;1(1):1-8. DOI:10.1177/228402650900100102
21. Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78(4):665-78.
DOI:10.1016/s0015-0282(02)03233-8
22. Candiani GB, Fedele L, Vercellini P, et al. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991;77(3):421-4.
23. Sutton CJ, Pooley AS, Ewen SP. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril. 1997;68(6):1070-4.
24. Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285-92.
25. Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738-43.
26. Younis JS, Shapso N, Ben-Sira Y, et al. Endometrioma surgery – a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2022;226(1):33-51. DOI:10.1016/j.ajog.2021.06.102
27. Ferrero S, Scala C, Racca A, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a casecontrol study. Fertil Steril. 2015;103(5):1236-43.
28. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health (Lond). 2015;11(5):693-99. DOI:10.2217/whe.15.56
29. Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Вопросы гинекологии, акушерства и перинатологии. 2015;14(6):29-33 [Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Gynecology, Obstetrics and Perinatology. 2015;14(6):29-33 (in Russian)].
30. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72:852-6. DOI:10.1016/s0015-0282(99)00367-2
31. Jiang D, Zhang X, Shi J, et al. Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;304:589-98. DOI:10.1007/s00404-021-06129-0
32. Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93(3):716-21. DOI:10.1016/j.fertn stert.2008.10.018
33. Hayasaka S, Ugajin T, Fujii O, et al. Risk factors for recurrence and re-recurrence of ovarian endometriomas after laparoscopic excision. J Obstet Gynaecol Res. 2011;37(6):581-5. DOI:10.1111/j.1447-0756.2010.01409.x
34. Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411-20. DOI:10.1097/01.AOG.0000265215.87717.8b
35. Sanchez A, Viganò P, Somigliana E. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217-30.
36. Sung HK, Seok KS. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reprod Sci. 2018;25(10):1515-22. DOI:10.1177/1933719118779733
37. Choi J, Jo M, Lee E, et al. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR. Fertil Steril. 2015;104(3):655-64.e651.
38. Ota Y, Andou M, Yanai S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord. 2015;7(2):63-7.
39. Zheng Q, Mao H, Xu Y, et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? Meta-analysis. Arch Gynecol Obstet. 2016;294(1):201-7. DOI:10.1007/s00404-016-4085-y
40. Johnson NP. Cochrane review: post-operative procedures for improving fertility following pelvic reproductive surgery. Hum Reprod Update. 2000;6(3):259-67.
41. Zakhari A, Delpero E, McKeown S, et al. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96-107. DOI:10.1093/ humupd/dmaa033
42. Zakhari A, Edwards D, Ryu M, et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(7):1503-10. DOI:10.1016/j. jmig.2020.05.007
43. Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24(1):61-70. DOI:10.1080/13625187.2018.1550576
44. Балан В.Е., Орлова С.А., Титченко Ю.П., и др. Безопасность длительного применения диеногеста (Визанна) при эндометриозе. Медицинский алфавит. 2017;1(3):12-5 [Balan VE, Orlova SA, Titchenko YuP, et al. Safety of prolonged use of dienogest (Visanne) with endometriosis. Medical Alphabet. 2017;1(3):12-5 (in Russian)].
45. Somigliana E, Arnoldi M, Benaglia L, et al. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod. 2008;23:1526-30.
46. Sallam HN, Garcia-Velasco JA, Dias S. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;25:CD004635.
47. Donnez J, Nisolle M, Gillerot S, et al. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62:63-6.
48. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
49. Gemmell LC, Webster KE, Kirtley S. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23:481-500.
50. Chandra A, Rho AM, Jeongm K, et al. Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma. Obstet Gynecol Sci. 2018;61(1):111-7. DOI:10.5468/ogs.2018.61.1.111
51. Takenaka M, Yano R, Hiraku Y, et al. Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts. J Obstet Gynaecol Res. 2015;41:1234-9.
52. Muraoka A, Osuka S, Yabuki A, et al. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod Biol Endocrinol. 2021;19(1):179. DOI:10.1186/s12958-021-00866-2
53. Vercellini P, Somigliana E, Viganò P, et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010;21:259-65.
54. Гусев Д.В., Прилуцкая В.Ю., Чернуха Г.Е. Рецидивы эндометриоидных кист яичников и возможные пути их снижения. Гинекология. 2020;22(3):34-8 [Gusev DV, Prilutskaya VY, Chernukha GE. Reccurence of endometrioid ovarian cysts and possible ways to its reduce. Gynecology. 2020;22(3):34-8 (in Russian)]. DOI:10.26442/20795696.2020.3.200144
55. Хащенко Е.П., Сивиринова А.С., Уварова Е.В. Современные принципы консервативного лечения эндометриоза в раннем репродуктивном возрасте. Акушерство и гинекология. 2022;1:31-41 [Khashchenko EP, Sivirinova AS, Uvarova EV. Sovremennye printsipy konservativnogo lecheniia endometrioza v rannem reproduktivnom vozraste. Akusherstvo i ginekologiia. 2022;1:31-41 (in Russian)].
56. Крутова В.А., Наумова Н.В., Болдовская Е.А. Хирургическое лечение эндометриом яичников в условиях интраоперационной эхографии. Кубанский научный медицинский вестник. 2020;27(1):49-58 [Krutova VA, Naumova NV, Boldovskaia EA. Khirurgicheskoe lechenie endometriom iaichnikov v usloviiakh intraoperatsionnoi ekhografii. Kubanskii nauchnyi meditsinskii vestnik. 2020;27(1):49-58 (in Russian)].
57. Дубинская Е.Д., Дутов А.А. Отдаленные результаты лечения бесплодия у пациенток с эндометриомами. Тенденции развития науки и образования. 2018;42(4):52-6 [Dubinskaia ED, Dutov AA. Otdalennye rezul'taty lecheniia besplodiia u patsientok s endometriomami. Tendentsii razvitiia nauki i obrazovaniia. 2018;42(4):52-6 (in Russian)].
58. Аскеров А.А., Сатыбалдиева А.Ж., Бозгорпоева Б.Б. Дифференцированный подход в диагностике и лечении эндометриоза у женщин репродуктивного возраста. Вестник Кыргызско-Российского Славянского университета. 2017;17(7):7-10 [Askerov AA, Satybaldieva AZh, Bozgorpoeva BB. Differentsirovannyi podkhod v diagnostike i lechenii endometrioza u zhenshchin reproduktivnogo vozrasta. Vestnik Kyrgyzsko-Rossiiskogo Slavianskogo universiteta. 2017;17(7):7-10 (in Russian)].
59. Гаспарян С.А., Василенко И.А., Попова О.С. Эндометриома: новая парадигма диагностики и лечебной тактики. Проблемы репродукции. 2019;25(6):78-85 [Gasparian SA, Vasilenko IA, Popova OS. Endometrioma: novaia paradigma diagnostiki i lechebnoi taktiki. Problemy reproduktsii. 2019;25(6):78-85 (in Russian)].
2. Surrey ES. Endometriosis and assisted reproductive technologies: maximizing outcomes. Semin Reprod Med. 2013;31:154-63.
3. Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1-15. DOI:10.1016/j.bpobgyn. 2018.06.001
4. Endometrioz. Klinicheskie rekomendatsii. 2020 (in Russian).
5. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.
6. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Management of endometriomas. Semin Reprod Med. 2017;35(1):25-30. DOI:10.1055/s-0036-1597126
7. Stern JE, Luke B, Tobias M, et al. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril. 2015;103:1438-45.
8. Cohen J, Ziyyat A, Naoura I, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2015;32:263-70.
9. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
10. Gater A, Taylor F, Seitz C, et al. Development and content validation of two new patientreported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS). J Patient Rep Outcomes. 2020;4:13.
11. Ruan HC, Zhu XM, Luo Q, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21:2521-9.
12. Pechenikova VA, Kostiuchek DF, Durasova EN. Kliniko-morfologicheskie i morfofunktsional'nye osobennosti endometrioza iaichnikov. Zhurnal akusherstva i zhenskikh boleznei. 2010;59(5):110-7 (in Russian).
13. Sanchez AM, Viganò P, Somigliana E, et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014;20(2):217-30.
14. Garcia-Velasco A, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496-501.
15. Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1043-57. DOI:10.1007/s00404-017-4640-1
16. Davydov AI, Strizhakov MA, Pashkov VM. Aspiracionnoe lechenie endometrioidnyh kist yaichnikov: za i protiv. Voprosy ginekologii, akusherstva i perinatologii. 2004;3(3):88-90 (in Russian).
17. Sidorova IS, Unanyan AL, Kogan EA. Clinicopathogenetic specificity of endometrioid ovarian affection: possibilities of prognosing and preventing relapses. Gynecology, Obstetrics and Perinatology. 2007;6(1):18-23 (in Russian).
18. Brosens I, Puttemans P, Gordts S, et al. Early stage management of ovarian endometrioma to prevent infertility. Facts Views Vis Obgyn. 2013;5(4):309-14.
19. Piriyev E, Schiermeier S, Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur J Obstet Gynecol Reprod Biol. 2021;263:20-4.
20. Vigano P, Somigliana E, Gentilin D, et al. Back to the original question in endometriosis: implantation or metaplasia? J Endometr. 2009;1(1):1-8. DOI:10.1177/228402650900100102
21. Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78(4):665-78.
DOI:10.1016/s0015-0282(02)03233-8
22. Candiani GB, Fedele L, Vercellini P, et al. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991;77(3):421-4.
23. Sutton CJ, Pooley AS, Ewen SP. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril. 1997;68(6):1070-4.
24. Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285-92.
25. Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738-43.
26. Younis JS, Shapso N, Ben-Sira Y, et al. Endometrioma surgery – a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2022;226(1):33-51. DOI:10.1016/j.ajog.2021.06.102
27. Ferrero S, Scala C, Racca A, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a casecontrol study. Fertil Steril. 2015;103(5):1236-43.
28. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health (Lond). 2015;11(5):693-99. DOI:10.2217/whe.15.56
29. Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Вопросы гинекологии, акушерства и перинатологии. 2015;14(6):29-33 [Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Gynecology, Obstetrics and Perinatology. 2015;14(6):29-33 (in Russian)].
30. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72:852-6. DOI:10.1016/s0015-0282(99)00367-2
31. Jiang D, Zhang X, Shi J, et al. Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;304:589-98. DOI:10.1007/s00404-021-06129-0
32. Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93(3):716-21. DOI:10.1016/j.fertn stert.2008.10.018
33. Hayasaka S, Ugajin T, Fujii O, et al. Risk factors for recurrence and re-recurrence of ovarian endometriomas after laparoscopic excision. J Obstet Gynaecol Res. 2011;37(6):581-5. DOI:10.1111/j.1447-0756.2010.01409.x
34. Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411-20. DOI:10.1097/01.AOG.0000265215.87717.8b
35. Sanchez A, Viganò P, Somigliana E. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217-30.
36. Sung HK, Seok KS. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reprod Sci. 2018;25(10):1515-22. DOI:10.1177/1933719118779733
37. Choi J, Jo M, Lee E, et al. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR. Fertil Steril. 2015;104(3):655-64.e651.
38. Ota Y, Andou M, Yanai S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord. 2015;7(2):63-7.
39. Zheng Q, Mao H, Xu Y, et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? Meta-analysis. Arch Gynecol Obstet. 2016;294(1):201-7. DOI:10.1007/s00404-016-4085-y
40. Johnson NP. Cochrane review: post-operative procedures for improving fertility following pelvic reproductive surgery. Hum Reprod Update. 2000;6(3):259-67.
41. Zakhari A, Delpero E, McKeown S, et al. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96-107. DOI:10.1093/ humupd/dmaa033
42. Zakhari A, Edwards D, Ryu M, et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(7):1503-10. DOI:10.1016/j. jmig.2020.05.007
43. Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24(1):61-70. DOI:10.1080/13625187.2018.1550576
44. Balan VE, Orlova SA, Titchenko YuP, et al. Safety of prolonged use of dienogest (Visanne) with endometriosis. Medical Alphabet. 2017;1(3):12-5 (in Russian).
45. Somigliana E, Arnoldi M, Benaglia L, et al. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod. 2008;23:1526-30.
46. Sallam HN, Garcia-Velasco JA, Dias S. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;25:CD004635.
47. Donnez J, Nisolle M, Gillerot S, et al. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62:63-6.
48. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
49. Gemmell LC, Webster KE, Kirtley S. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23:481-500.
50. Chandra A, Rho AM, Jeongm K, et al. Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma. Obstet Gynecol Sci. 2018;61(1):111-7. DOI:10.5468/ogs.2018.61.1.111
51. Takenaka M, Yano R, Hiraku Y, et al. Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts. J Obstet Gynaecol Res. 2015;41:1234-9.
52. Muraoka A, Osuka S, Yabuki A, et al. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod Biol Endocrinol. 2021;19(1):179. DOI:10.1186/s12958-021-00866-2
53. Vercellini P, Somigliana E, Viganò P, et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010;21:259-65.
54. Gusev DV, Prilutskaya VY, Chernukha GE. Reccurence of endometrioid ovarian cysts and possible ways to its reduce. Gynecology. 2020;22(3):34-8 (in Russian). DOI:10.26442/20795696.2020.3.200144
55. Khashchenko EP, Sivirinova AS, Uvarova EV. Sovremennye printsipy konservativnogo lecheniia endometrioza v rannem reproduktivnom vozraste. Akusherstvo i ginekologiia. 2022;1:31-41 (in Russian).
56. Krutova VA, Naumova NV, Boldovskaia EA. Khirurgicheskoe lechenie endometriom iaichnikov v usloviiakh intraoperatsionnoi ekhografii. Kubanskii nauchnyi meditsinskii vestnik. 2020;27(1):49-58 (in Russian).
57. Dubinskaia ED, Dutov AA. Otdalennye rezul'taty lecheniia besplodiia u patsientok s endometriomami. Tendentsii razvitiia nauki i obrazovaniia. 2018;42(4):52-6 (in Russian).
58. Askerov AA, Satybaldieva AZh, Bozgorpoeva BB. Differentsirovannyi podkhod v diagnostike i lechenii endometrioza u zhenshchin reproduktivnogo vozrasta. Vestnik Kyrgyzsko-Rossiiskogo Slavianskogo universiteta. 2017;17(7):7-10 (in Russian).
59. Gasparian SA, Vasilenko IA, Popova OS. Endometrioma: novaia paradigma diagnostiki i lechebnoi taktiki. Problemy reproduktsii. 2019;25(6):78-85 (in Russian).
2. Surrey ES. Endometriosis and assisted reproductive technologies: maximizing outcomes. Semin Reprod Med. 2013;31:154-63.
3. Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1-15. DOI:10.1016/j.bpobgyn. 2018.06.001
4. Эндометриоз. Клинические рекомендации. 2020 [Endometrioz. Klinicheskie rekomendatsii. 2020 (in Russian)].
5. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.
6. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Management of endometriomas. Semin Reprod Med. 2017;35(1):25-30. DOI:10.1055/s-0036-1597126
7. Stern JE, Luke B, Tobias M, et al. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril. 2015;103:1438-45.
8. Cohen J, Ziyyat A, Naoura I, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2015;32:263-70.
9. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
10. Gater A, Taylor F, Seitz C, et al. Development and content validation of two new patientreported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS). J Patient Rep Outcomes. 2020;4:13.
11. Ruan HC, Zhu XM, Luo Q, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21:2521-9.
12. Печеникова В.А., Костючек Д.Ф., Дурасова Е.Н. Клинико-морфологические и морфофункциональные особенности эндометриоза яичников. Журнал акушерства и женских болезней. 2010;59(5):110-7 [Pechenikova VA, Kostiuchek DF, Durasova EN. Kliniko-morfologicheskie i morfofunktsional'nye osobennosti endometrioza iaichnikov. Zhurnal akusherstva i zhenskikh boleznei. 2010;59(5):110-7 (in Russian)].
13. Sanchez AM, Viganò P, Somigliana E, et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014;20(2):217-30.
14. Garcia-Velasco A, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496-501.
15. Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1043-57. DOI:10.1007/s00404-017-4640-1
16. Давыдов А.И., Стрижаков М.А., Пашков В.М. Аспирационное лечение эндометриоидных кист яичников: за и против. Вопросы гинекологии, акушерства и перинатологии. 2004;3(3):88-90 [Davydov AI, Strizhakov MA, Pashkov VM. Aspiracionnoe lechenie endometrioidnyh kist yaichnikov: za i protiv. Voprosy ginekologii, akusherstva i perinatologii. 2004;3(3):88-90 (in Russian)].
17. Сидорова И.С., Унанян А.Л., Коган Е.А., и др. Клинико-патогенетические особенности эндометриоидных поражений яичников: возможности прогнозирования и профилактики рецидивов. Вопросы гинекологии, акушерства и перинатологии. 2007;6(1):18-23 [Sidorova IS, Unanyan AL, Kogan EA. Clinicopathogenetic specificity of endometrioid ovarian affection: possibilities of prognosing and preventing relapses. Gynecology, Obstetrics and Perinatology. 2007;6(1):18-23 (in Russian)].
18. Brosens I, Puttemans P, Gordts S, et al. Early stage management of ovarian endometrioma to prevent infertility. Facts Views Vis Obgyn. 2013;5(4):309-14.
19. Piriyev E, Schiermeier S, Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur J Obstet Gynecol Reprod Biol. 2021;263:20-4.
20. Vigano P, Somigliana E, Gentilin D, et al. Back to the original question in endometriosis: implantation or metaplasia? J Endometr. 2009;1(1):1-8. DOI:10.1177/228402650900100102
21. Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78(4):665-78.
DOI:10.1016/s0015-0282(02)03233-8
22. Candiani GB, Fedele L, Vercellini P, et al. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991;77(3):421-4.
23. Sutton CJ, Pooley AS, Ewen SP. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril. 1997;68(6):1070-4.
24. Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285-92.
25. Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738-43.
26. Younis JS, Shapso N, Ben-Sira Y, et al. Endometrioma surgery – a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2022;226(1):33-51. DOI:10.1016/j.ajog.2021.06.102
27. Ferrero S, Scala C, Racca A, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a casecontrol study. Fertil Steril. 2015;103(5):1236-43.
28. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health (Lond). 2015;11(5):693-99. DOI:10.2217/whe.15.56
29. Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Вопросы гинекологии, акушерства и перинатологии. 2015;14(6):29-33 [Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Gynecology, Obstetrics and Perinatology. 2015;14(6):29-33 (in Russian)].
30. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72:852-6. DOI:10.1016/s0015-0282(99)00367-2
31. Jiang D, Zhang X, Shi J, et al. Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;304:589-98. DOI:10.1007/s00404-021-06129-0
32. Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93(3):716-21. DOI:10.1016/j.fertn stert.2008.10.018
33. Hayasaka S, Ugajin T, Fujii O, et al. Risk factors for recurrence and re-recurrence of ovarian endometriomas after laparoscopic excision. J Obstet Gynaecol Res. 2011;37(6):581-5. DOI:10.1111/j.1447-0756.2010.01409.x
34. Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411-20. DOI:10.1097/01.AOG.0000265215.87717.8b
35. Sanchez A, Viganò P, Somigliana E. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217-30.
36. Sung HK, Seok KS. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reprod Sci. 2018;25(10):1515-22. DOI:10.1177/1933719118779733
37. Choi J, Jo M, Lee E, et al. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR. Fertil Steril. 2015;104(3):655-64.e651.
38. Ota Y, Andou M, Yanai S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord. 2015;7(2):63-7.
39. Zheng Q, Mao H, Xu Y, et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? Meta-analysis. Arch Gynecol Obstet. 2016;294(1):201-7. DOI:10.1007/s00404-016-4085-y
40. Johnson NP. Cochrane review: post-operative procedures for improving fertility following pelvic reproductive surgery. Hum Reprod Update. 2000;6(3):259-67.
41. Zakhari A, Delpero E, McKeown S, et al. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96-107. DOI:10.1093/ humupd/dmaa033
42. Zakhari A, Edwards D, Ryu M, et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(7):1503-10. DOI:10.1016/j. jmig.2020.05.007
43. Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24(1):61-70. DOI:10.1080/13625187.2018.1550576
44. Балан В.Е., Орлова С.А., Титченко Ю.П., и др. Безопасность длительного применения диеногеста (Визанна) при эндометриозе. Медицинский алфавит. 2017;1(3):12-5 [Balan VE, Orlova SA, Titchenko YuP, et al. Safety of prolonged use of dienogest (Visanne) with endometriosis. Medical Alphabet. 2017;1(3):12-5 (in Russian)].
45. Somigliana E, Arnoldi M, Benaglia L, et al. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod. 2008;23:1526-30.
46. Sallam HN, Garcia-Velasco JA, Dias S. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;25:CD004635.
47. Donnez J, Nisolle M, Gillerot S, et al. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62:63-6.
48. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
49. Gemmell LC, Webster KE, Kirtley S. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23:481-500.
50. Chandra A, Rho AM, Jeongm K, et al. Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma. Obstet Gynecol Sci. 2018;61(1):111-7. DOI:10.5468/ogs.2018.61.1.111
51. Takenaka M, Yano R, Hiraku Y, et al. Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts. J Obstet Gynaecol Res. 2015;41:1234-9.
52. Muraoka A, Osuka S, Yabuki A, et al. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod Biol Endocrinol. 2021;19(1):179. DOI:10.1186/s12958-021-00866-2
53. Vercellini P, Somigliana E, Viganò P, et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010;21:259-65.
54. Гусев Д.В., Прилуцкая В.Ю., Чернуха Г.Е. Рецидивы эндометриоидных кист яичников и возможные пути их снижения. Гинекология. 2020;22(3):34-8 [Gusev DV, Prilutskaya VY, Chernukha GE. Reccurence of endometrioid ovarian cysts and possible ways to its reduce. Gynecology. 2020;22(3):34-8 (in Russian)]. DOI:10.26442/20795696.2020.3.200144
55. Хащенко Е.П., Сивиринова А.С., Уварова Е.В. Современные принципы консервативного лечения эндометриоза в раннем репродуктивном возрасте. Акушерство и гинекология. 2022;1:31-41 [Khashchenko EP, Sivirinova AS, Uvarova EV. Sovremennye printsipy konservativnogo lecheniia endometrioza v rannem reproduktivnom vozraste. Akusherstvo i ginekologiia. 2022;1:31-41 (in Russian)].
56. Крутова В.А., Наумова Н.В., Болдовская Е.А. Хирургическое лечение эндометриом яичников в условиях интраоперационной эхографии. Кубанский научный медицинский вестник. 2020;27(1):49-58 [Krutova VA, Naumova NV, Boldovskaia EA. Khirurgicheskoe lechenie endometriom iaichnikov v usloviiakh intraoperatsionnoi ekhografii. Kubanskii nauchnyi meditsinskii vestnik. 2020;27(1):49-58 (in Russian)].
57. Дубинская Е.Д., Дутов А.А. Отдаленные результаты лечения бесплодия у пациенток с эндометриомами. Тенденции развития науки и образования. 2018;42(4):52-6 [Dubinskaia ED, Dutov AA. Otdalennye rezul'taty lecheniia besplodiia u patsientok s endometriomami. Tendentsii razvitiia nauki i obrazovaniia. 2018;42(4):52-6 (in Russian)].
58. Аскеров А.А., Сатыбалдиева А.Ж., Бозгорпоева Б.Б. Дифференцированный подход в диагностике и лечении эндометриоза у женщин репродуктивного возраста. Вестник Кыргызско-Российского Славянского университета. 2017;17(7):7-10 [Askerov AA, Satybaldieva AZh, Bozgorpoeva BB. Differentsirovannyi podkhod v diagnostike i lechenii endometrioza u zhenshchin reproduktivnogo vozrasta. Vestnik Kyrgyzsko-Rossiiskogo Slavianskogo universiteta. 2017;17(7):7-10 (in Russian)].
59. Гаспарян С.А., Василенко И.А., Попова О.С. Эндометриома: новая парадигма диагностики и лечебной тактики. Проблемы репродукции. 2019;25(6):78-85 [Gasparian SA, Vasilenko IA, Popova OS. Endometrioma: novaia paradigma diagnostiki i lechebnoi taktiki. Problemy reproduktsii. 2019;25(6):78-85 (in Russian)].
________________________________________________
2. Surrey ES. Endometriosis and assisted reproductive technologies: maximizing outcomes. Semin Reprod Med. 2013;31:154-63.
3. Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1-15. DOI:10.1016/j.bpobgyn. 2018.06.001
4. Endometrioz. Klinicheskie rekomendatsii. 2020 (in Russian).
5. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.
6. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Management of endometriomas. Semin Reprod Med. 2017;35(1):25-30. DOI:10.1055/s-0036-1597126
7. Stern JE, Luke B, Tobias M, et al. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril. 2015;103:1438-45.
8. Cohen J, Ziyyat A, Naoura I, et al. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2015;32:263-70.
9. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
10. Gater A, Taylor F, Seitz C, et al. Development and content validation of two new patientreported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS). J Patient Rep Outcomes. 2020;4:13.
11. Ruan HC, Zhu XM, Luo Q, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21:2521-9.
12. Pechenikova VA, Kostiuchek DF, Durasova EN. Kliniko-morfologicheskie i morfofunktsional'nye osobennosti endometrioza iaichnikov. Zhurnal akusherstva i zhenskikh boleznei. 2010;59(5):110-7 (in Russian).
13. Sanchez AM, Viganò P, Somigliana E, et al. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Human Reproduction Update. 2014;20(2):217-30.
14. Garcia-Velasco A, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496-501.
15. Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch Gynecol Obstet. 2018;297:1043-57. DOI:10.1007/s00404-017-4640-1
16. Davydov AI, Strizhakov MA, Pashkov VM. Aspiracionnoe lechenie endometrioidnyh kist yaichnikov: za i protiv. Voprosy ginekologii, akusherstva i perinatologii. 2004;3(3):88-90 (in Russian).
17. Sidorova IS, Unanyan AL, Kogan EA. Clinicopathogenetic specificity of endometrioid ovarian affection: possibilities of prognosing and preventing relapses. Gynecology, Obstetrics and Perinatology. 2007;6(1):18-23 (in Russian).
18. Brosens I, Puttemans P, Gordts S, et al. Early stage management of ovarian endometrioma to prevent infertility. Facts Views Vis Obgyn. 2013;5(4):309-14.
19. Piriyev E, Schiermeier S, Römer T. Coexistence of endometriomas with extraovarian endometriosis and adhesions. Eur J Obstet Gynecol Reprod Biol. 2021;263:20-4.
20. Vigano P, Somigliana E, Gentilin D, et al. Back to the original question in endometriosis: implantation or metaplasia? J Endometr. 2009;1(1):1-8. DOI:10.1177/228402650900100102
21. Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78(4):665-78.
DOI:10.1016/s0015-0282(02)03233-8
22. Candiani GB, Fedele L, Vercellini P, et al. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991;77(3):421-4.
23. Sutton CJ, Pooley AS, Ewen SP. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertil Steril. 1997;68(6):1070-4.
24. Shakiba K, Bena JF, McGill KM, et al. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285-92.
25. Muzii L, Achilli C, Lecce F, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738-43.
26. Younis JS, Shapso N, Ben-Sira Y, et al. Endometrioma surgery – a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2022;226(1):33-51. DOI:10.1016/j.ajog.2021.06.102
27. Ferrero S, Scala C, Racca A, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a casecontrol study. Fertil Steril. 2015;103(5):1236-43.
28. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health (Lond). 2015;11(5):693-99. DOI:10.2217/whe.15.56
29. Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Вопросы гинекологии, акушерства и перинатологии. 2015;14(6):29-33 [Strygina VA, Solomatina AA, Bulatova LS, et al. Recurrence of ovarian endometriosis. Gynecology, Obstetrics and Perinatology. 2015;14(6):29-33 (in Russian)].
30. Jain S, Dalton ME. Chocolate cysts from ovarian follicles. Fertil Steril. 1999;72:852-6. DOI:10.1016/s0015-0282(99)00367-2
31. Jiang D, Zhang X, Shi J, et al. Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;304:589-98. DOI:10.1007/s00404-021-06129-0
32. Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010;93(3):716-21. DOI:10.1016/j.fertn stert.2008.10.018
33. Hayasaka S, Ugajin T, Fujii O, et al. Risk factors for recurrence and re-recurrence of ovarian endometriomas after laparoscopic excision. J Obstet Gynaecol Res. 2011;37(6):581-5. DOI:10.1111/j.1447-0756.2010.01409.x
34. Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411-20. DOI:10.1097/01.AOG.0000265215.87717.8b
35. Sanchez A, Viganò P, Somigliana E. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217-30.
36. Sung HK, Seok KS. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reprod Sci. 2018;25(10):1515-22. DOI:10.1177/1933719118779733
37. Choi J, Jo M, Lee E, et al. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR. Fertil Steril. 2015;104(3):655-64.e651.
38. Ota Y, Andou M, Yanai S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord. 2015;7(2):63-7.
39. Zheng Q, Mao H, Xu Y, et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? Meta-analysis. Arch Gynecol Obstet. 2016;294(1):201-7. DOI:10.1007/s00404-016-4085-y
40. Johnson NP. Cochrane review: post-operative procedures for improving fertility following pelvic reproductive surgery. Hum Reprod Update. 2000;6(3):259-67.
41. Zakhari A, Delpero E, McKeown S, et al. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96-107. DOI:10.1093/ humupd/dmaa033
42. Zakhari A, Edwards D, Ryu M, et al. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(7):1503-10. DOI:10.1016/j. jmig.2020.05.007
43. Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24(1):61-70. DOI:10.1080/13625187.2018.1550576
44. Balan VE, Orlova SA, Titchenko YuP, et al. Safety of prolonged use of dienogest (Visanne) with endometriosis. Medical Alphabet. 2017;1(3):12-5 (in Russian).
45. Somigliana E, Arnoldi M, Benaglia L, et al. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod. 2008;23:1526-30.
46. Sallam HN, Garcia-Velasco JA, Dias S. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;25:CD004635.
47. Donnez J, Nisolle M, Gillerot S, et al. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62:63-6.
48. Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101:1031-7.
49. Gemmell LC, Webster KE, Kirtley S. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23:481-500.
50. Chandra A, Rho AM, Jeongm K, et al. Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma. Obstet Gynecol Sci. 2018;61(1):111-7. DOI:10.5468/ogs.2018.61.1.111
51. Takenaka M, Yano R, Hiraku Y, et al. Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts. J Obstet Gynaecol Res. 2015;41:1234-9.
52. Muraoka A, Osuka S, Yabuki A, et al. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod Biol Endocrinol. 2021;19(1):179. DOI:10.1186/s12958-021-00866-2
53. Vercellini P, Somigliana E, Viganò P, et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online. 2010;21:259-65.
54. Gusev DV, Prilutskaya VY, Chernukha GE. Reccurence of endometrioid ovarian cysts and possible ways to its reduce. Gynecology. 2020;22(3):34-8 (in Russian). DOI:10.26442/20795696.2020.3.200144
55. Khashchenko EP, Sivirinova AS, Uvarova EV. Sovremennye printsipy konservativnogo lecheniia endometrioza v rannem reproduktivnom vozraste. Akusherstvo i ginekologiia. 2022;1:31-41 (in Russian).
56. Krutova VA, Naumova NV, Boldovskaia EA. Khirurgicheskoe lechenie endometriom iaichnikov v usloviiakh intraoperatsionnoi ekhografii. Kubanskii nauchnyi meditsinskii vestnik. 2020;27(1):49-58 (in Russian).
57. Dubinskaia ED, Dutov AA. Otdalennye rezul'taty lecheniia besplodiia u patsientok s endometriomami. Tendentsii razvitiia nauki i obrazovaniia. 2018;42(4):52-6 (in Russian).
58. Askerov AA, Satybaldieva AZh, Bozgorpoeva BB. Differentsirovannyi podkhod v diagnostike i lechenii endometrioza u zhenshchin reproduktivnogo vozrasta. Vestnik Kyrgyzsko-Rossiiskogo Slavianskogo universiteta. 2017;17(7):7-10 (in Russian).
59. Gasparian SA, Vasilenko IA, Popova OS. Endometrioma: novaia paradigma diagnostiki i lechebnoi taktiki. Problemy reproduktsii. 2019;25(6):78-85 (in Russian).
Авторы
Т.А. Макаренко, Д.Е. Галкина*, Е.А. Борисова
ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого», Красноярск, Россия
*dashsemch@mail.ru
Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia
*dashsemch@mail.ru
ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого», Красноярск, Россия
*dashsemch@mail.ru
________________________________________________
Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia
*dashsemch@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.